Compare SRPT & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRPT | LMAT |
|---|---|---|
| Founded | 1980 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.0B |
| IPO Year | 1997 | 2006 |
| Metric | SRPT | LMAT |
|---|---|---|
| Price | $21.37 | $84.01 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 28 | 6 |
| Target Price | $25.68 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 2.7M | 143.6K |
| Earning Date | 02-25-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 27.40 |
| EPS | N/A | ★ 2.32 |
| Revenue | ★ $2,413,715,000.00 | $240,866,000.00 |
| Revenue This Year | $13.99 | $15.17 |
| Revenue Next Year | N/A | $9.07 |
| P/E Ratio | ★ N/A | $36.96 |
| Revenue Growth | ★ 47.15 | 13.07 |
| 52 Week Low | $10.42 | $71.42 |
| 52 Week High | $120.05 | $105.55 |
| Indicator | SRPT | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 48.35 | 47.96 |
| Support Level | $20.10 | $84.34 |
| Resistance Level | $21.88 | $88.21 |
| Average True Range (ATR) | 1.42 | 2.76 |
| MACD | -0.14 | 0.20 |
| Stochastic Oscillator | 30.10 | 53.26 |
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.